Pascal Biosciences Inc. announced the testing of cannabinoids in human subjects for its immune stimulatory program in cancer. Furthermore, the Company has filed an international patent application to protect this work for future therapeutic indications. Since discovering cannabinoids that can stimulate the immune system, Pascal has extensively studied many different cannabinoids in a variety of immune stimulatory assays. More than 375 cannabinoids from numerous sources have been examined, including natural cannabinoids from Cannabis (known as phytocannabinoids), synthetic cannabinoids prepared by chemists, and endocannabinoids naturally found in the human body. Specific natural cannabinoids have been identified that have potent activity in immune assays and also have a good safety profile. In order to protect future efforts, Pascal has filed a patent on these discoveries.